Doximity Inc (NYSE: DOCS) on Tuesday, soared 4.56% from the previous trading day, before settling in for the closing price of $55.96. Within the past 52 weeks, DOCS’s price has moved between $25.00 and $85.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 37.42%. The company achieved an average annual earnings per share of -0.24%. With a float of $132.76 million, this company’s outstanding shares have now reached $137.78 million.
The extent of productivity of a business whose workforce counts for 830 workers is very important to gauge. In terms of profitability, gross margin is 90.2%, operating margin of 39.94%, and the pretax margin is 46.21%.
Doximity Inc (DOCS) Insider Updates
Observing investor behavior towards Health Information Services industry stocks is more important than anything else. The insider ownership of Doximity Inc is 29.32%, while institutional ownership is 67.47%. The most recent insider transaction that took place on Jun 02 ’25, was worth 105,780. In this transaction Director of this company sold 2,000 shares at a rate of $52.89, taking the stock ownership to the 16,618 shares. Before that another transaction happened on Jun 02 ’25, when Company’s Director proposed sale 2,000 for $52.89, making the entire transaction worth $105,780.
Doximity Inc (DOCS) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -0.24% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.60% during the next five years compared to 79.45% growth over the previous five years of trading.
Doximity Inc (NYSE: DOCS) Trading Performance Indicators
Doximity Inc (DOCS) is currently performing well based on its current performance indicators. A quick ratio of 6.92 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.27. Likewise, its price to free cash flow for the trailing twelve months is 41.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.11, a number that is poised to hit 0.30 in the next quarter and is forecasted to reach 1.57 in one year’s time.
Technical Analysis of Doximity Inc (DOCS)
The latest stats from [Doximity Inc, DOCS] show that its last 5-days average volume of 1.91 million was inferior to 2.53 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 58.62%. Additionally, its Average True Range was 2.10.
During the past 100 days, Doximity Inc’s (DOCS) raw stochastic average was set at 27.92%, which indicates a significant decrease from 88.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.11% in the past 14 days, which was lower than the 70.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $55.29, while its 200-day Moving Average is $53.84. Now, the first resistance to watch is $59.82. This is followed by the second major resistance level at $61.13. The third major resistance level sits at $63.34. If the price goes on to break the first support level at $56.30, it is likely to go to the next support level at $54.09. Assuming the price breaks the second support level, the third support level stands at $52.78.
Doximity Inc (NYSE: DOCS) Key Stats
Market capitalization of the company is 10.99 billion based on 187,826K outstanding shares. Right now, sales total 570,400 K and income totals 223,190 K. The company made 138,290 K in profit during its latest quarter, and 62,460 K in sales during its previous quarter.